Research Article
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission
Table 5
Lymphocytes CD3, CD4, CD8, CD4/CD8 ratio, CD19, and NK cells in patients with mild, severe, and critical COVID-19 (median and IQR).
| | | Mild (n = 39) | Severe (n = 23) | Critical (n = 14) | value |
| | CD3 | 1411 (986–2137) | 938 (639–1426) | 507 (238–938) | < 0.05 | | CD4 | 950 (653–1390) | 794 (463–1034) | 256. (163–594) | = 0.00 | | CD8 | 478 (317–685) | 327 (132–408) | 190 (63–253) | = 0.00 | | CD19 | 256 (170–358) | 166 (84–218) | 93 (74–158) | < 0.05 | | NK | 170 (130–287) | 143 (72–320) | 65 (37–123) | < 0.05 | | CD4/CD8 | 2.2 (1.5–2.9) | 2.1 (1.5–3.4) | 2.2 (1.0–2.8) | > 0.05 |
|
|
Abbreviations: COVID-19, coronavirus disease 2019; NK, natural killer.
|
